Financial Consulate’s Amphastar Pharmaceuticals AMPH Stock Holding History

Financial Consulate’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$52	Buy	+2	New	+$43	﹤0.01%	1861

Other funds holding AMPH

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Illumine Investment Management Poulsbo, Washington $144M AUM 33.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Financial Consulate's AMPH Position: Q3 2026 in Review

Financial Consulate opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 2 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings.

35 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

Financial Consulate held 2 shares of Amphastar Pharmaceuticals worth $52 as of Q3 2026.
Amphastar Pharmaceuticals was a new Financial Consulate position in Q3 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1861 holding.
35 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.